Kalos Therapeutics, Inc. — Form D
Kalos Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-02-12. The offering totals $3.5M, of which $20K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-02-12
- Form: D
- Accession: 0001569466-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.5M
- Amount sold: $20K
- Remaining: $3.4M
- Investors: 1
- Date of first sale: 2012-12-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-191719
Issuer
- Name: Kalos Therapeutics, Inc.
- CIK: 0001569466
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4370 LA JOLLA VILLAGE DRIVE, SUITE 400, SAN DIEGO, CA, 92122
- Phone: 858-552-6890
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| George F Colberg | Director | San Diego, CA |
| Michael F Mitrow | Director | San Diego, CA |
| Gregory F Witchel | Director | San Diego, CA |
| James Merritt | Executive Officer | San Diego, CA |
| Gregory F Witchel | Executive Officer | San Diego, CA |
| George Colberg | Director | San Diego, CA |
| George Colberg | Executive Officer | San Diego, CA |
| Derek Vest | Director | San Diego, CA |
| Larry Stambaugh | Director | San Diego, CA |
Other filings by this issuer (1)
More